CAR‑T therapy against common myeloma was recently registered in Israel, and its official price is expected to be announced in January. About one‑third of the patients who received it in the study remained disease‑free after five years, and Johnson & Johnson are already developing a version where the cells will be engineered inside the patient’s body. John Reed, senior vice president at the company: "Each patient is essentially a product in its own right."
Automatic translation by Google
Curated from Ynet Health. Classified as Health by AI, which sometimes makes mistakes.
Simple, useful, and kind of fun. The post Doctor shares 60-second dementia test that can help adults spot early mental decline appeared first on Upworthy.
Many people dealing with excess weight know the feeling: every attempt ends up in the same place. Weight loss, weight gain, and the sense that eventually "maybe nothing will work for me." Professor Itamar Raz, an expert in obesity and diabetes, knows this feeling well from the clinic, and suggests changing the mindset.
What should you do when a doctor recommends a critical and expensive medication that is not included in the public health basket, but the insurance company rejects the request, claiming the insurance policy lacks coverage? Before you exhaust savings or break down over a denial letter from the insurer, it is important to understand the financing mechanisms operating behind the scenes. A guide to exercising patient rights in Israel.
